rxstat › Shortages › Sitagliptin Metformin

Sitagliptin Metformin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Sitagliptin Metformin products are in shortage in Canada (7 of 23 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 20, 2026.
Products affected
7 of 23
In shortage since
Jul 22, 2025
Est. full return
Jul 20, 2026
Reports on file
68
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
500MG 50MG · TABLET · PRO DOC LIMITEE
DIN 02534223 · since Apr 15, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN/METFORMIN XR
100MG 1000MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02506297 · since Jun 30, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
1000MG 50MG · TABLET · TEVA CANADA LIMITED
DIN 02520516 · since Jun 10, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
850MG 50MG · TABLET · TEVA CANADA LIMITED
DIN 02520508 · since Mar 10, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
850MG 50MG · TABLET · TEVA CANADA LIMITED
DIN 02520508 · since Mar 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 1000MG · TABLET · APOTEX INC
DIN 02509431 · since Jul 22, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
850MG 50MG · TABLET · APOTEX INC
DIN 02509423 · since Sep 30, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 500MG · TABLET · APOTEX INC
DIN 02509415 · since Oct 8, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
500MG 50MG · TABLET · APOTEX INC
DIN 02509415 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 1000MG · TABLET · APOTEX INC
DIN 02509431 · since Sep 16, 2025, no end estimate · Disruption of the manufacture of the drug.
To be discontinued
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 850MG · TABLET · PRO DOC LIMITEE
DIN 02534231
To be discontinued
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 1000MG · TABLET · PRO DOC LIMITEE
DIN 02534258

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Sitagliptin Metformin is currently affected by 7 active shortage reports filed with Health Canada by PRO DOC LIMITEE, APOTEX INC, TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Sitagliptin Metformin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BD).

Recent changes

Common questions

When will Sitagliptin Metformin be back in stock in Canada?

The latest manufacturer estimate is Jul 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Sitagliptin Metformin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (blood glucose lowering drugs, excl. insulins)

Widespread shortageCanagliflozin2 of 4 reported products affected · est. return Dec 4, 2026Widespread shortageSitagliptin12 of 24 reported products affected · est. return Jan 7, 2027Widespread shortageTirzepatide6 of 6 reported products affectedPartial shortageDapagliflozin4 of 11 reported products affected · est. return Jul 24, 2026Partial shortageDapagliflozin Metformin2 of 6 reported products affected · est. return Jul 24, 2026Partial shortageGliclazide2 of 20 reported products affected

All blood glucose lowering drugs, excl. insulins shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.